Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Pascale Meert

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
The European Respiratory Journal|February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology AssemblyAdrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Annals of Intensive Care|April 18, 2023
ICU admission for solid cancer patients treated with immune checkpoint inhibitorsAnne-Claire Toffart, Anne-Pascale Meert, Florent Wallet, et al.
Transplantation and Cellular Therapy|October 4, 2020
Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM StudyLaveena Munshi, Michael Darmon, Marcio Soares, et al.
Leukemia & Lymphoma|October 3, 2018
Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignanciesXavier Mignard, Lucie Biard, Virginie Lemiale, et al.
Frontiers in Oncology|February 13, 2015
Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working PartyThierry Berghmans, Lieveke Ameye, Jean-Jacques Lafitte, et al.
Journal of Critical Care|December 14, 2020
Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational datasetMagali Bisbal, Michael Darmon, Colombe Saillard, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
Critical Care Medicine|April 23, 2020
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique StudyVirginie Lemiale, Stéphanie Pons, Adrien Mirouse, et al.
Annals of Intensive Care|June 14, 2017
Red blood cell transfusion in the resuscitation of septic patients with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie Lemiale, et al.
Annals of Intensive Care|September 18, 2016
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)David Schnell, Elie Azoulay, Dominique Benoit, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|February 16, 2018
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology AssemblyAdrien Costantini, Marta Grynovska, Francesca Lucibello, et al.
Annals of Intensive Care|April 18, 2023
ICU admission for solid cancer patients treated with immune checkpoint inhibitorsAnne-Claire Toffart, Anne-Pascale Meert, Florent Wallet, et al.
Transplantation and Cellular Therapy|October 4, 2020
Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM StudyLaveena Munshi, Michael Darmon, Marcio Soares, et al.
Leukemia & Lymphoma|October 3, 2018
Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignanciesXavier Mignard, Lucie Biard, Virginie Lemiale, et al.
Frontiers in Oncology|February 13, 2015
Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working PartyThierry Berghmans, Lieveke Ameye, Jean-Jacques Lafitte, et al.
Journal of Critical Care|December 14, 2020
Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational datasetMagali Bisbal, Michael Darmon, Colombe Saillard, et al.
Plos One|April 1, 2016
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, et al.
Critical Care Medicine|April 23, 2020
Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique StudyVirginie Lemiale, Stéphanie Pons, Adrien Mirouse, et al.
Annals of Intensive Care|June 14, 2017
Red blood cell transfusion in the resuscitation of septic patients with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie Lemiale, et al.
Annals of Intensive Care|September 18, 2016
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)David Schnell, Elie Azoulay, Dominique Benoit, et al.
Pageof 9